Literature DB >> 21395342

One-pot synthesis of 2-amino-indole-3-carboxamide and analogous.

Kan Wang1, Eberhardt Herdtweck, Alexander Dömling.   

Abstract

An efficient one-pot, two-step solution-phase synthetic method was developed to synthesize twenty-three 2-amino-indole-3-carboxamides (3) from 2-halonitrobenzene (1) or heterocyclic analogous and cyanoacetamides (2). In this sequence, first, intermediate 2-cyano-2-(2-nitrophenyl)acetamide (4) was generated under basic condition via S(NAr) reaction; after direct addition of hydrochloric acid solution, FeCl(3), and Zn powder, indole 3 was generated via reduction/cyclization process.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21395342      PMCID: PMC3124116          DOI: 10.1021/co100040z

Source DB:  PubMed          Journal:  ACS Comb Sci        ISSN: 2156-8944            Impact factor:   3.784


  18 in total

1.  Active and inhibited human catalase structures: ligand and NADPH binding and catalytic mechanism.

Authors:  C D Putnam; A S Arvai; Y Bourne; J A Tainer
Journal:  J Mol Biol       Date:  2000-02-11       Impact factor: 5.469

2.  Discovery of piperidin-4-yl-aminopyrimidines as HIV-1 reverse transcriptase inhibitors. N-benzyl derivatives with broad potency against resistant mutant viruses.

Authors:  Denis J Kertesz; Christine Brotherton-Pleiss; Minmin Yang; Zhanguo Wang; Xianfeng Lin; Zongxing Qiu; Donald R Hirschfeld; Shelley Gleason; Taraneh Mirzadegan; Pete W Dunten; Seth F Harris; Armando G Villaseñor; Julie Qi Hang; Gabrielle M Heilek; Klaus Klumpp
Journal:  Bioorg Med Chem Lett       Date:  2010-05-16       Impact factor: 2.823

3.  Dabigatran etexilate.

Authors:  Bengt I Eriksson; Helen Smith; Uma Yasothan; Peter Kirkpatrick
Journal:  Nat Rev Drug Discov       Date:  2008-07       Impact factor: 84.694

4.  Intramolecular hydrogen bonding in medicinal chemistry.

Authors:  Bernd Kuhn; Peter Mohr; Martin Stahl
Journal:  J Med Chem       Date:  2010-03-25       Impact factor: 7.446

Review 5.  Dabigatran etexilate, a new oral direct thrombin inhibitor, for stroke prevention in patients with atrial fibrillation.

Authors:  Fazeel M Siddiqui; Adnan I Qureshi
Journal:  Expert Opin Pharmacother       Date:  2010-06       Impact factor: 3.889

6.  Robust generation of lead compounds for protein-protein interactions by computational and MCR chemistry: p53/Hdm2 antagonists.

Authors:  Anna Czarna; Barbara Beck; Stuti Srivastava; Grzegorz M Popowicz; Siglinde Wolf; Yijun Huang; Michal Bista; Tad A Holak; Alexander Dömling
Journal:  Angew Chem Int Ed Engl       Date:  2010-07-19       Impact factor: 15.336

7.  Identification of novel inhibitors of urokinase via NMR-based screening.

Authors:  P J Hajduk; S Boyd; D Nettesheim; V Nienaber; J Severin; R Smith; D Davidson; T Rockway; S W Fesik
Journal:  J Med Chem       Date:  2000-10-19       Impact factor: 7.446

8.  One-step synthesis of pyrido[1,2-a]benzimidazole derivatives by a novel multicomponent reaction of chloroacetonitrile, malononitrile, aromatic aldehyde, and pyridine.

Authors:  Chao Guo Yan; Qi Fang Wang; Xiao Kai Song; Jing Sun
Journal:  J Org Chem       Date:  2009-01-16       Impact factor: 4.354

9.  Cyanoacetamide MCR (III): three-component Gewald reactions revisited.

Authors:  Kan Wang; Dabin Kim; Alexander Dömling
Journal:  J Comb Chem       Date:  2010 Jan-Feb

10.  Synthesis and cytotoxic activity of 5,6-heteroaromatically annulated pyridine-2,4-diamines.

Authors:  C Willemann; R Grünert; P J Bednarski; R Troschütz
Journal:  Bioorg Med Chem       Date:  2009-05-12       Impact factor: 3.641

View more
  2 in total

1.  Cyanoacetamides (IV): versatile one-pot route to 2-quinoline-3-carboxamides.

Authors:  Kan Wang; Eberhardt Herdtweck; Alexander Dömling
Journal:  ACS Comb Sci       Date:  2012-04-18       Impact factor: 3.784

2.  Discovery of chromenes as inhibitors of macrophage migration inhibitory factor.

Authors:  Tjie Kok; Hannah Wapenaar; Kan Wang; Constantinos G Neochoritis; Tryfon Zarganes-Tzitzikas; Giordano Proietti; Nikolaos Eleftheriadis; Katarzyna Kurpiewska; Justyna Kalinowska-Tłuścik; Robbert H Cool; Gerrit J Poelarends; Alexander Dömling; Frank J Dekker
Journal:  Bioorg Med Chem       Date:  2017-12-24       Impact factor: 3.641

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.